Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer

T Oliver1, G Mead

  • 1Medical College, Royal London Hospital, UK.

Current Opinion in Oncology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Innovation in germ cell tumor management continues, focusing on early testicular investigation and novel therapies. Research explores new markers and adjuvant treatments to improve outcomes for testicular cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.

BMC cardiovascular disorders·2024
Same author

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Investigation of reaction force magnitude and orientation during supine thoracic thrust manipulation applied to intervertebral and costovertebral regions.

Musculoskeletal science & practice·2020
Same author

Exploring adults' experiences of sedentary behaviour and participation in non-workplace interventions designed to reduce sedentary behaviour: a thematic synthesis of qualitative studies.

BMC public health·2019
Same author

The volume of liver irradiated during modern free-breathing breast radiotherapy: Implications for theory and practice.

Radiography (London, England : 1995)·2019
Same author

Deep vein thrombosis, an unreported first manifestation of polyglandular autoimmune syndrome type III.

Endocrinology, diabetes & metabolism case reports·2016
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Urology
  • Cancer Research

Background:

  • Germ cell tumors (GCTs) have a high cure rate (>90%), but ongoing research is crucial for further advancements.
  • Extragonadal GCTs often present with evidence of tumor rejection, highlighting the importance of testicular examination in undiagnosed primary cancers to prevent treatment delays.
  • Testicular atrophy may precede malignancy, potentially explaining the rise in testicular cancer and decline in sperm counts, and links to environmental exposures like those in Vietnam veterans.

Purpose of the Study:

  • To review current innovations and future directions in the management of germ cell tumors.
  • To emphasize the importance of investigating the testis in patients with undiagnosed primary cancer.
  • To explore novel therapeutic strategies and prognostic markers for GCTs.

Related Experiment Videos

Main Methods:

  • Analysis of large patient databases for improved prognostication.
  • Review of salvage therapies including high-dose chemotherapy with bone marrow rescue.
  • Investigation into potential new chemotherapeutic agents like carboplatin.
  • Evaluation of adjuvant chemotherapy strategies for stage I disease.
  • Exploration of biomarkers such as lactate dehydrogenase-1 and isochrome 12p.
  • Assessment of risks associated with specific chemotherapies (e.g., etoposide) and comparison of adjuvant treatment modalities (radiotherapy, chemotherapy, surgery).

Main Results:

  • High cure rates for GCTs are established, yet innovations persist.
  • Early detection through testicular investigation is critical to improve prognosis.
  • New agents like carboplatin are being considered as alternatives to cisplatin.
  • Adjuvant chemotherapy is gaining interest for stage I disease, with a focus on predictive markers.
  • Potential biomarkers include lactate dehydrogenase-1 and isochrome 12p.
  • Concerns exist regarding secondary malignancies (acute myeloid leukemia) from certain therapies like etoposide.
  • Radiotherapy and chemotherapy may be more effective than surgery in reducing second testicular tumor incidence.

Conclusions:

  • Continued innovation in germ cell tumor management is essential.
  • Investigating the testis in cases of undiagnosed primary cancer is vital to prevent delayed treatment and improve outcomes.
  • Further research into novel agents, predictive biomarkers, and adjuvant therapies, including radiotherapy and chemotherapy, is warranted to optimize GCT treatment and minimize long-term risks.